Cilostazol (Pletal): risks of cardiovascular and bleeding events

Source:
GOV UK
Publisher:
Medicines and Healthcare products Regulatory Agency
Publication date:
11 December 2014

Abstract

Indication restricted to second-line treatment and contraindicated with some cardiovascular conditions and medicines Furthermore, cilostazol is now contraindicated in patients with any of the following: Unstable ang…